Patient Engagement That Drives Clinical Trial Success - Patient Reminders

Patient recruitment is the #1 driver of clinical trial costs, consuming on average 32% of the trial budget. Yet poor patient retention threatens the value of this critical effort, in turn placing your entire study at risk. In fact, the average patient dropout rate in a Phase III trial is 30%. The overall rate may be worse. A Tufts Center for the Study of Drug Development report revealed that retention rates in the Phase II and Phase III protocols studied fell from 69% to 48% in recent years.

An intuitive, proactive patient engagement and retention approach can improve your trial’s patient sustainability, and reduce the costs associated with having to re-recruit new patients into the study. The solution also engages and motivates patients to comply with the protocol, helping retain the statistical power necessary to show the true effect of your study drug.